Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial (vol 23, pg P183, 2023)

被引：0
|
作者：
Khoo, S. H.
FitzGerald, R.
Saunders, G.
机构：
来源：
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E1 / E1
页数：1
相关论文
共 50 条
  • [31] Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial
    Kliewer, Kara L.
    Murray-Petzold, Cristin
    Collins, Margaret H.
    Abonia, Juan P.
    Bolton, Scott M.
    Ditommaso, Lauren A.
    Martin, Lisa J.
    Zhang, Xue
    Mukkada, Vincent A.
    Putnam, Philip E.
    Kellner, Erinn S.
    Devonshire, Ashley L.
    Schwartz, Justin
    Kunnathur, Vidhya A.
    Rosenberg, Chen E.
    Lyles, John L.
    Shoda, Tetsuo
    Klion, Amy
    Rothenberg, Marc E.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (09): : 803 - 815
  • [32] Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
    Nakamori, Masayuki
    Nakatani, Daisaku
    Sato, Tomoharu
    Hasuike, Yuhei
    Kon, Seiko
    Saito, Toshio
    Nakamura, Harumasa
    Takahashi, Masanori P.
    Hida, Eisuke
    Komaki, Hirofumi
    Matsumura, Tsuyoshi
    Takada, Hiroto
    Mochizuki, Hideki
    ECLINICALMEDICINE, 2024, 67
  • [33] Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial
    Rosenkranz, Stephan
    Feldman, Jeremy
    McLaughlin, Vallerie V.
    Rischard, Franz
    Lange, Tobias J.
    White, R. James
    Peacock, Andrew J.
    Gerhardt, Felix
    Ebrahimi, Ramin
    Brooks, Gabriel
    Satler, Carol
    Frantz, Robert P.
    LANCET RESPIRATORY MEDICINE, 2022, 10 (01): : 35 - 46
  • [34] Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey (vol 398, pg 213, 2021)
    Tanriover, M. D.
    Doganay, H. L.
    Akova, M.
    LANCET, 2022, 399 (10323): : 436 - 436
  • [35] Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine KCONVAC in Chinese Children: Randomized, Double-blind, Placebo-controlled Phase 1 and 2 Trials
    Liu, Jiankai
    Huang, Baoying
    Li, Guifan
    Huang, Tao
    Wang, Danni
    Zhang, Li
    Deng, Yao
    Chang, Xianyun
    Liu, Yafei
    Li, Weiqi
    Zhang, Siyuan
    Huang, Weijin
    Tan, Wenjie
    Gao, Lidong
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (12) : 1136 - 1142
  • [36] Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
    Hartemann, Agnes
    Bensimon, Gilbert
    Payan, Christine A.
    Jacqueminet, Sophie
    Bourron, Olivier
    Nicolas, Nathalie
    Fonfrede, Michele
    Rosenzwajg, Michelle
    Bernard, Claude
    Klatzmann, David
    LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (04): : 295 - 305
  • [37] Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial
    Henderson, Emily J.
    Lord, Stephen R.
    Brodie, Matthew A.
    Gaunt, Daisy M.
    Lawrence, Andrew D.
    Close, Jacqueline C. T.
    Whone, A. L.
    Ben-Shlomo, Y.
    LANCET NEUROLOGY, 2016, 15 (03): : 249 - 258
  • [38] Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
    Maher, Toby M.
    Corte, Tamera J.
    Fischer, Aryeh
    Kreuter, Michael
    Lederer, David J.
    Molina-Molina, Maria
    Axmann, Judit
    Kirchgaessler, Klaus-Uwe
    Samara, Katerina
    Gilberg, Frank
    Cottin, Vincent
    LANCET RESPIRATORY MEDICINE, 2020, 8 (02): : 147 - 157
  • [39] Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial (vol 2, pg 565, 2017)
    Meyer, T.
    Fox, R.
    Yt, Ma
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (09): : E6 - E6
  • [40] Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial
    Judson, Ian
    Morden, James P.
    Kilburn, Lucy
    Leahy, Michael
    Benson, Charlotte
    Bhadri, Vivek
    Campbell-Hewson, Quentin
    Cubedo, Ricardo
    Dangoor, Adam
    Fox, Lisa
    Hennig, Ivo
    Jarman, Katy
    Joubert, Warren
    Kernaghan, Sarah
    Lopez Pousa, Antonio
    McNeil, Catriona
    Seddon, Beatrice
    Snowdon, Claire
    Tattersall, Martin
    Toms, Christy
    Martinez Trufero, Javier
    Bliss, Judith M.
    LANCET ONCOLOGY, 2019, 20 (07): : 1023 - 1034
12345